Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC
Apply
Curcumin & EGFR-TKIs
A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step